Research Article

Utilization Patterns of IV Iron and Erythropoiesis Stimulating Agents in Anemic Chronic Kidney Disease Patients: A Multihospital Study

Table 3

Demographic characteristics of the study sample.

VariableESA + IV IronESA alone Total

Demographic characteristics

n (%)n (%)N (%)

Age group (years)*
 18–30369 (5.53)4728 (6.20)5097 (6.14)
 31–501476 (22.10)19349 (25.37)20825 (25.11)
 51–642074 (31.06)24546 (32.18)26620 (32.09)
 ≥652759 (41.31)27647 (36.25)30406 (36.66)

Race*
 White3348 (50.13)30504 (40)33852 (40.81)
 Black2299 (34.43)32010 (41.97)34310 (41.36)
 Hispanic514 (7.70)7742 (10.15)8256 (9.95)
 Other517 (7.74)6013 (7.88)6530 (7.87)

Gender
 Male3615 (54.13)39940 (52.37)43555 (52.51)
 Female3063 (45.87)36330 (47.63)39393 (47.49)

Primary payer*
 Commercial/Private payer1157 (17.33)11092 (14.54)12249 (14.77)
 Medicare4588 (68.70)53834 (70.58)58422 (70.43)
 Medicaid710 (10.63)9026 (11.83)9736 (11.74)
 Self-pay 97 (1.45) 924 (1.21) 1021 (1.23)
 Other126 (1.89)1394 (1.83)1520 (1.83)

* Differences between the study groups were statistically significance at .